LB Pharmaceuticals Appoints Susan Kozauer Chief Medical Officer

Company: LB Pharmaceuticals · Event Type: Executive Appointment · New CMO: Susan G. Kozauer, M.D. · Context: NOVA 2 Phase 3 Schizophrenia Readout Expected H1 2027 · Date: September 15, 2026 (effective September 14) Summary LB Pharmaceuticals appointed Susan G. Kozauer, M.D., chief medical officer…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Pfizer – SF R&D Site Closure
Tempus Acquires Personalis for $1.5 Billion
PTC Therapeutics Wins $211M Bankruptcy Auction for Sangamo’s Fabry Disease Gene Therapy
Waypoint Bio – China IIT CAR-T Strategy